IL6 and melanoma: In the future, it would also be interesting to test whether the increased expression of the tyrosine kinase receptors (EGFR and PDGFRβ) is independent of or in any way related to the enhanced IL‐6 and/or WNT5A signalling and increased migration and invasion during the development of BRAFi resistance in melanoma.